Oncolytic virotherapy for the therapy of sarcoma

Described is a parvovirus for the treatment of mesenchymal tumors, preferably malignant bone tumors such as localized and metastasized bone tumors, in particular osteosarcoma and Ewing's sarcoma. A preferred parvovirus is the replication competent parvovirus H-1PV.

Saved in:
Bibliographic Details
Main Authors FRANK-STOHR, MONIKA, LACROIX, JEANINNE, KIS, ZOLTAN, LEUCHS, BARBARA, SCHLEHOFER, JORG, ROMMELAERE, JEAN
Format Patent
LanguageEnglish
Published 29.08.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described is a parvovirus for the treatment of mesenchymal tumors, preferably malignant bone tumors such as localized and metastasized bone tumors, in particular osteosarcoma and Ewing's sarcoma. A preferred parvovirus is the replication competent parvovirus H-1PV.
Bibliography:Application Number: AU20120269386